Hillsborough, NJ, United States of America

Shyam Babu Karki

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Celgene Corporation. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shyam Babu Karki. Retrieved from https://idiyas.com/inventor/shyam-babu-karki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shyam Babu Karki: Innovator in Pharmaceutical Compositions

Introduction

Shyam Babu Karki is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions and methods.

Latest Patents

Karki holds 2 patents that focus on pharmaceutical compositions. His latest patents include formulations comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile. These patents detail methods of preparing and using these pharmaceutical compositions, which are designed for oral dosage formulations.

Career Highlights

Shyam Babu Karki is currently associated with Celgene Corporation, where he continues to advance his research and development efforts in the pharmaceutical industry. His work has contributed to the creation of effective therapeutic solutions.

Collaborations

Karki collaborates with esteemed colleagues, including Anjali Agrawal and Ming J Chen, to further enhance the impact of his innovations in the pharmaceutical sector.

Conclusion

Shyam Babu Karki is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly influence medical treatments. His contributions reflect a commitment to innovation and excellence in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…